CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: The effect of the combination of tiplaxtinin and IM on the CFC production of NBM CD34+ cells, IM-sensitive CML CD34+ cells, and IM-resistant CML CD34+ cells was studied.